ArticleAesthetic surgery journal. Open forum2026
Implant-Free Breast Volume Restoration Using Abdominal Free Flaps in Nononcologic Patients: A Retrospective Cohort Study.
Article in Aesthetic surgery journal. Open forum, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
18 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Abdominal free flaps are established in oncologic breast reconstruction but are less frequently used for implant-free breast volume restoration in nononcologic patients. The aim of this study was to describe the indications, operative characteristics, complications, follow-up, and secondary procedures associated with abdominal free-flap breast reconstruction or augmentation in a nononcologic cohort. The authors performed a retrospective single-center cohort study of consecutive patients who underwent deep inferior epigastric perforator (DIEP) or muscle-sparing transverse rectus abdominis myocutaneous (msTRAM) flap transfer for nononcologic indications between 2004 and 2025. Patients undergoing reconstruction for oncologic breast disease were excluded. Clinical, operative, and outcome data were extracted from medical records. Surgical complications were categorized according to timing and requirement for reoperation. Elective secondary procedures were recorded separately. Fourteen patients underwent 22 abdominal free-flap reconstructions, including 19 DIEP and 3 msTRAM flaps. Primary indications were congenital breast deformity in 8 patients, primary autologous augmentation in 3, revision after aesthetic augmentation in 2, and sequelae of breast abscess in 1. Implant-associated problems were present in 8 patients. Median follow-up was 35.6 months (range, 8.2-248.5 months). No total flap loss occurred. Unplanned reoperations were required in 4 of 22 reconstructions, including 1 during the index admission and 3 after discharge. Elective secondary procedures were performed in 4 of 14 patients. In this small, heterogeneous retrospective cohort, abdominal free flaps restored breast volume without total flap loss. Unplanned reoperations and elective secondary procedures occurred during the observed follow-up period.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.